Ia. Brezovich et al., Effect of Foley catheters on seed positions and urethral dose in I-125 andPd-103 prostate implants, INT J RAD O, 49(5), 2001, pp. 1461-1468
Citations number
17
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: To estimate the perturbation of seed position and urethral dose, s
ubsequent to withdrawal of urethral catheters.
Methods and Materials: A mathematical model based on the volume incompressi
bility of tissues was used to compute seed positions and doses following re
moval of the Foley. The model assumed that the central axis of the urethra
remains stationary, and that prostate tissue and seeds move radially toward
the center of the urethra to fill the void left by the catheter. Seed moti
on has also been measured using transrectal ultrasound.
Results: Based on the computations, seeds located originally close to the u
rethra travel relatively large distances toward the urethra upon Foley remo
val, whereas seeds located further away move substantially less. This seed
motion leads to higher urethral doses than shown in a standard treatment pl
an. Dose enhancements increase with catheter size, decrease,vith increasing
prostate volume, are more pronounced for Pd-103 than for I-125, and range
between 3.5% and 32.4%. Postimplant dosimetry is equally affected if images
are taken with urethral catheters in plate, showing lower urethral doses t
han actually delivered. Preliminary ultrasound based measurements of seed m
otion agree with the theory.
Conclusion: During the implantation procedure, 12 fr or smaller urethral ca
theters are preferable to larger diameter catheters if urine drainage is su
fficient. Treatment planners should avoid planning seeds at 5 mm or closer
from the urethra. Special caution is indicated in prostates having about 20
cm(3) or smaller volumes, and when Pd-103 is used. Postimplant dosimetry i
s susceptible to the same errors. (C) 2001 Elsevier Science Inc.